Evidence map›Paper›PMID 23554695›Full record

ArticleJournal of biomedical research2011

The role of intracellular protein O-glycosylation in cell adhesion and disease.

Meryem Bektas, David S Rubenstein

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Understanding the Renal Fibrotic Process in Leptospirosis.International journal of molecular sciences · 2021
    Review
  9. Role of Glycosylation in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Review
  12. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.Journal of bioenergetics and biomembranes · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Mucin-Type O-Glycosylation in Invertebrates.Molecules (Basel, Switzerland) · 2015
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Meryem BektasDepartment of Dermatology.
David S Rubenstein
University of North Carolina at Chapel Hill · US

Funding

ADHESION JUNCTION REGULATION IN NORMAL AND DISEASED SKINR01AI049427 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBENSTEIN, DAVID S · 2001 to 2011
$3.2M
Adhesion Junction Regulation in Normal and Diseased SkinR56AI049427 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUBENSTEIN, DAVID S · 2012 to 2012
$409k
NIAID NIH HHS R01 AI049427NIAID NIH HHS R56 AI049427
6 · The paper itself

Abstract

Post-translational protein modification, including phosphorylation, is generally quick and reversible, facilitating rapid biologic adjustments to altered cellular physiologic demands. In addition to protein phosphorylation, other post-translational modifications have been identified. Intracellular protein O-glycosylation, the addition of the simple sugar O-linked N-acetylglucosamine (O-GlcNAc) to serine/threonine residues, is a relatively recently identified post-translational modification that has added to the complexity by which protein function is regulated. Two intracellular enzymes, O-GlcNAc transferase and O-GlcNAcase, catalyze the addition and removal, respectively, of O-GlcNAc to serine and threonine side-chain hydroxyl groups. Numerous proteins, including enzymes, transcription factors, receptors and structural proteins have been shown to be modified by intracellular O-glycosylation. In this review, the mechanism and relevance of O-GlcNAc protein modification are discussed in the context of cell adhesion and several representative diseases.

Indexed as

cancercell adhesiondiabetesO-GlcNAcO-glycosylation

Identifiers

PMID23554695
PMCPMC3597071
OpenAlexW2084231038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.